Quality Assurance
Every peptide we sell undergoes rigorous analytical testing to ensure the highest standards of purity, identity, and consistency.
Solid-Phase Synthesis
Peptides are synthesised using Fmoc-based SPPS with automated synthesizers.
Purification
Reverse-phase HPLC purification removes truncated sequences and impurities.
Analytical Testing
HPLC purity analysis + mass spectrometry identity confirmation.
Lyophilisation
Freeze-dried for maximum stability and shipped with full COA.
HPLC Purity Analysis
High-Performance Liquid Chromatography (HPLC) separates and quantifies the peptide content of each batch. Our standard is >= 98% purity, verified by peak area integration. The resulting chromatogram is included in every Certificate of Analysis.
| Grade | HPLC Purity | Use Case |
|---|---|---|
| Research | ≥ 95% | General in vitro studies |
| High-Purity | ≥ 98% | Quantitative assays |
| Ultra-Purity | ≥ 99% | Clinical standards |
Mass Spectrometry Confirmation
Every batch is analysed by mass spectrometry (MS) to confirm the molecular weight of the synthesised peptide. The observed mass must match the theoretical mass within 1 Dalton. This ensures that the correct sequence was synthesised and that no major deletion peptides are present.
Residual Solvent Testing
After lyophilisation, trace solvents from synthesis remain. We test for and comply with ICH Q3C limits:
- • Acetonitrile: < 410 ppm (Class 2)
- • TFA (trifluoroacetic acid): < 250 ppm
- • DMF (dimethylformamide): < 880 ppm
Certificate of Analysis (COA)
Every order includes a COA with HPLC chromatogram, MS data, and residual solvent levels. Verify any batch using our online tool.
Verify a Batch